|
Real-time Estimate
Cboe BZX
02:27:57 2026-08-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.165 USD | -1.71% |
|
-0.63% | +14.91% |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| Aug. 11 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.71% | -0.63% | +8.22% | -15.96% | +14.91% | -14.36% | -23.11% | -46.72% | -55.81% | 368M | |
| -0.11% | -1.67% | +0.14% | +20.82% | +5.21% | +1.80% | +19.90% | -24.82% | +203.70% | 48.84B | |
| +1.01% | +4.12% | +18.64% | +48.24% | +168.70% | +487.16% | +622.55% | +704.28% | - | 45.44B | |
| +1.90% | +2.72% | +18.83% | +25.92% | +21.48% | +15.58% | +91.17% | +27.28% | +1,185.48% | 41.22B | |
| +0.57% | -0.72% | +18.73% | +40.09% | +7.40% | +25.74% | +13.14% | -5.06% | +221.68% | 39.71B | |
| -2.74% | -2.74% | +11.21% | +8.73% | +13.41% | +17.30% | +56.10% | -13.22% | +144.26% | 32.6B | |
| +1.47% | -1.00% | +0.11% | +6.06% | - | - | - | - | - | 16.25B | |
| -1.29% | -2.65% | +11.65% | +40.12% | +4.95% | +27.34% | +136.08% | +232.23% | +2,022.61% | 16.67B | |
| -0.49% | -0.34% | -2.03% | +15.95% | +11.63% | +3.45% | +29.14% | -40.60% | +88.27% | 14.08B | |
| -1.64% | -0.49% | +27.73% | +87.17% | +40.68% | +78.77% | +41.09% | -32.55% | +236.65% | 13.68B | |
| -0.13% | +2.04% | +1.67% | +48.49% | -7.28% | -5.38% | -32.51% | -29.78% | +122.86% | 13.07B | |
| +2.08% | +8.76% | +44.17% | +92.37% | +79.92% | +69.20% | +80.87% | -36.30% | - | 12.37B | |
| -0.07% | +0.33% | +1.05% | +62.93% | +23.09% | +35.84% | -7.48% | -38.50% | +171.66% | 11.28B | |
| -2.83% | -6.45% | -12.87% | +7.64% | -14.53% | +72.36% | +501.75% | +289.04% | +2,350.00% | 10.57B | |
| -1.94% | -0.78% | +20.81% | +14.74% | +24.78% | +688.72% | +1,602.69% | +53.15% | - | 10.51B | |
| -0.00% | -0.08% | +0.32% | +70.90% | +78.31% | +264.73% | +455.22% | - | - | 10.15B | |
| -0.45% | +5.90% | +16.95% | +55.88% | +79.80% | +179.37% | +720.88% | +236.55% | +1,247.94% | 10.26B | |
| -0.71% | +9.30% | +7.88% | +50.38% | +53.98% | +174.67% | +507.56% | +140.53% | - | 10.1B | |
| +0.49% | +6.60% | +11.58% | -18.53% | -25.32% | +36.03% | +52.07% | +55.35% | +71.40% | 9.74B | |
| -3.98% | -10.97% | +2.42% | +13.66% | -16.04% | -36.80% | - | - | - | 9.32B | |
| Average | -0.54% | +1.09% | +10.36% | +33.78% | +29.74% | +111.66% | +270.40% | +86.52% | +616.21% | 18.81B | |
| Weighted average by Cap. | -0.14% | +0.05% | +11.55% | +34.03% | +37.14% | +115.34% | +224.97% | +119.95% | +581.39% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
